1. OXA-48-like carbapenemases: the phantom menace;Poirel;J Antimicrob Chemother,2012
2. The global ascendency of OXA-48-type carbapenemases;Pitout;Clin Microbiol Rev,2019
3. Livermore DM, Nicolau DP, Hopkins KL, Meunier D. ‘CRE, CRO, CPE and CPO’: terms no longer adequate in an era of new antibiotics and regional carbapenemase epidemiology. Clin Infect Dis [In press].
4. Heterogeneous hydrolytic features for OXA-48-like β-lactamases;Oueslati;J Antimicrob Chemother,2014
5. Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model;Wiskirchen;Antimicrob Agents Chemother,2014